Health Highlights, April 23, 2021
Pfizer and Moderna Vaccines Effective Against New NYC Variant, Two Studies Show
The Pfizer-BioNTech and Moderna COVID-19 vaccines protect against serious illness and death from the coronavirus variant first identified in New York city, two new studies show.
The B.1.526 variant was first detected in November and accounted for nearly half of cases diagnosed in the city as of April 13. City officials have said the variant may be more contagious and may be able to avoid the immune response triggered by the vaccines, The New York Times reported.
But the two independent studies found that antibodies stimulated by the Pfizer-BioNTech and Moderna COVID-19 vaccines are only slightly less effective against the variant than the original form of the novel coronavirus.
The findings -- which haven't been peer-reviewed -- are based on laboratory experiments with blood samples from small numbers of vaccinated people, the Times reported.
The studies add to growing evidence that the two vaccines protect against all coronavirus variants identified so far.
"We're not seeing big differences," Michel Nussenzweig, a Rockefeller University immunologist who was a researcher on one of the studies, told the Times.
The bottom line? "Get vaccinated," he added.
"The take-home message is that the vaccines are going to work against the New York variant and the South African variant and the U.K. variant," Nathan Landau, a virologist at N.Y.U.'s Grossman School of Medicine who led the other study, told the Times.
© 2021 HealthDay. All rights reserved.
Posted: April 2021
Further Support and Information on COVID-19
Read this next
MONDAY, May 10, 2021 -- When young women land in the emergency room with chest pain, they wait longer and get less treatment than their male counterparts, a preliminary study...
MONDAY, May 10, 2021 -- Taking nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen doesn't make COVID-19 worse or more deadly, a new study finds. When the pandemic...
MONDAY, May 10, 2021 -- Organ transplant recipients remain vulnerable to infection with the new coronavirus even after receiving both doses of two-dose vaccines, new research...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.